Name
Licensing opportunities from Athenion
Organization name
Athenion GmbH
Profile
Athenion owns and develops a unique portfolio of advanced-stage therapeutics and medical technologies. For all of our portfolio products, we own the exclusive development, marketing and licensing rights in Europe, North-America, Japan and a number of other countries.
All of our compounds, technologies and products are in an advanced stage of development - some have already regulatory market approval in certain countries.
Athenion offers these technologies for in-licensing to partners from health care, medical technology and related industries. We look for partners that have proven scientific and marketing competence in the particular field of application.
Our current out-licensing portfolio consists of offerings in the following fields/markets:
Ethical drugs
Neurology
- Non-Alzheimer age-related dementia
- CNS Trauma
- Brain Edema
- Enhancement of cognitive functions, attention, stress tolerance
- Insomnia
- Stroke
Dermatology
- Psoriasis
- Erysipela
- Acne
- anti-inflammatory/cytokine inhibition
- wound healing - reduction of scar (keloid) formation
Cardiovascular
- Restoration of oxygenation/perfusion in compromised tissues
Anti-Infectives
- Hepatitis B, C, D
- AIDS
- Salmonelliosis
- Tuberculosis
Technologies
- Pain-level monitoring for anesthesia
- Attention monitoring for drivers (automotive vigilance surveillance, sleep prevention)
Non-prescription, OTC and Supplements
- IBS
- Arthritis
- Insomnia
- ADD
- Hyperactivity
- Diarrhoea
To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register